• Explore /
  • Poster
  • / Phase 1 trial of trametinib alone and in combination with dabrafenib in children and adolescents with relapsed solid tumors or neurofibromatosis type 1 (NF1) progressive plexiform neurofibromas (PN).

Phase 1 trial of trametinib alone and in combination with dabrafenib in children and adolescents with relapsed solid tumors or neurofibromatosis type 1 (NF1) progressive plexiform neurofibromas (PN).

Abstract Poster

Authors

null

Birgit Geoerger

Gustave Roussy, Villejuif, France

Birgit Geoerger , Christopher L. Moertel , James Whitlock , Geoffrey Brian McCowage , Mark W. Kieran , Alberto Broniscer , Darren R Hargrave , Pooja Hingorani , Lindsay Baker Kilburn , Sabine Mueller , Lillian Tseng , Noelia Nebot , Kohinoor Dasgupta , Mark W. Russo , Elizabeth Fox

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Pediatric Oncology

Track

Pediatric Oncology

Sub Track

Pediatric Solid Tumors

Clinical Trial Registration Number

NCT02124772

Citation

J Clin Oncol 36, 2018 (suppl; abstr 10537)

DOI

10.1200/JCO.2018.36.15_suppl.10537

Abstract #

10537

Poster Bd #

210

Abstract Disclosures

Similar Posters

First Author: Alain Patrick Algazi

First Author: Patricia LoRusso

First Author: Brigitte C. Widemann

First Author: April K.S. Salama